Viscovery successfully expands data mining business to life sciences
[News Viscovery]
Vienna / Austria, April 2012 Data mining-specialist Viscovery Software GmbH continues to develop its data-mining business in the life science branch. In collaboration with mother company Biomax Informatics AG, Viscovery is contributing to the establishment of a new data center for CIRO+ in the Netherlands by providing data mining software and consulting. This is the first integrated patient-centric knowledge management system for patient stratification and targeted therapy in chronic obstructive pulmonary disease (COPD).
"The CIRO+ Data Center allows, for the first time, to better understand patient outcome based on systematic pre- and post-assessment data of more than 3,000 patients over the past 6 years with up to 6,000 clinical data points captured for each patient. The impact of being able to exploit clinical knowledge effectively using state-of-the-art technology cannot be overestimated. This applies to both improved patient care and better management of treatment costs”, as Prof. Wouters, Chairman Board of Directors CIRO+, explained at the announcement of the CIRO+ Data Center launch.
In addition to this project, the Viscovery data-mining approach using SOM methodology is supporting medical research with identification of possible candidates for biomarkers by allowing clinical data to be examined and clustered with genetic data. Recently, projects in drug efficacy as well as the classification of clinical data to distinguish responsive and unresponsive patients have been successfully completed.
The international Cancermotisys research project (biomax.com/project/cancermotisys), examining the specific effects of stomach cancer drugs, is in its third year and close to completion. Viscovery has been involved in examining the relationship between cancer cell motility and genetic expression data.
Data Mining-specialist Viscovery success continued in 2011
[News Viscovery]
Vienna / Austria, March 2012 Vienna-based Viscovery Software GmbH reported successful results for 2011. As in the previous year, licensing generated 70% of the revenue. The SOM business (data mining based on self-organizing maps) underwent continued internationalization: over 90% of the volume was from international customers representing all continents. New customers acquired in 2011 include Qantas Airways, Oklahoma State Department of Health, iiNet Limited, Toyota Motor Corporation, Emirates Telecommunications Corporation, and Kissei Pharmaceutical Co., Ltd.
In addition, many research institutes and universities chose Viscovery in 2011, including University of Pretoria, University of Strathclyde, Osaka City University, Kyoto University, Tokyo Institute of Technology, and Micro Ram Enterprise. Product-distribution partnerships were further strengthened, in particular with Dynelytics (formerly SPSS Switzerland) which was extended to countries outside of Switzerland.
Consulting companies use Viscovery in analytics services
[News Viscovery]
Vienna / Austria, August 2011 Consulting companies of all sizes have used Viscovery in diverse consulting projects for many years. Now Viscovery has entered into an agreement to provide Deloitte, the global professional services organization, with a Viscovery SOMine license, in connection with Deloitte’s AsOne client service offering (www.deloitte.com/asone).
The AsOne archetypes are presented in the book AsOne by Merdad Baghai and James Quigley, which was listed in the New York Times Top 10 economic books. These eight archetypes of work behavior were defined using clusters created with the Viscovery software from customer data.
Data mining specialist Viscovery expands into the Life Sciences
[News Viscovery]
Vienna / Austria, May 2011 The data mining specialist Viscovery successfully established itself in the Life Science sector in 2010. In positive synergy with its parent company, Biomax Informatics, they carried out projects in the food industry and in pharmaceutical and medical research. In these fields, Viscovery® Data Mining with SOMs (Self-Organizing Maps) helps researchers find potential biomarker candidates by analyzing and clustering clinical and genetic data.
Viscovery's participation as a partner in the international CANCERMOTISYS research project studying the specific effect of drugs against stomach cancer (www.biomax.com/project/cancermotisys) is already in its third year. In this project, Viscovery is examining, among other things, the relationship between the motility of cancer cells and gene expression data.